Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0610
+0.0050 (8.93%)
Feb 11, 2026, 2:55 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 4.87 million as of February 10, 2026. Its market cap has decreased by -61.79% in one year.
Market Cap
4.87M
Enterprise Value
12.13M
Revenue
180.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 4.87M, an increase of 56.18%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.87M | -16.59% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Little Green Pharma | 37.44M |
| Vitura Health | 35.13M |
| IDT Australia | 19.66M |
| Peak Processing | 17.03M |
| Cann Group | 12.71M |
| Epsilon Healthcare | 12.29M |
| Percheron Therapeutics | 8.70M |
| ECS Botanics Holdings | 7.98M |